Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
9.20
-0.42 (-4.37%)
At close: May 28, 2025, 4:00 PM
9.22
+0.02 (0.22%)
After-hours: May 28, 2025, 4:00 PM EDT
Upstream Bio Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Upstream Bio stock ranges from a low of $38 to a high of $75. The average analyst price target of $56.5 forecasts a 514.13% increase in the stock price over the next year.
Price Target: $56.50 (+514.13%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for Upstream Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +313.04% | Nov 5, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Nov 5, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $75 | Buy | Initiates | $75 | +715.22% | Nov 5, 2024 |
Financial Forecast
Revenue This Year
1.50M
from 2.37M
Decreased by -36.92%
Revenue Next Year
1.37M
from 1.50M
Decreased by -8.63%
EPS This Year
-2.59
from -5.58
EPS Next Year
-2.95
from -2.59
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.1M | 3.2M | 3.3M |
| Avg | 1.5M | 1.4M | 1.6M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 31.1% | 112.1% | 142.2% |
| Avg | -36.9% | -8.6% | 13.7% |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.64 | -2.84 | -2.47 |
| Avg | -2.59 | -2.95 | -2.70 |
| Low | -2.56 | -3.06 | -2.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.